Cost-Effectiveness Analysis of Insulin Aspart 30 Versus Insulin Glargine in Patients with Type 2 Diabetes in China

WU Jing, HE Xiao-ning, LIU Yan-hui

Chinese Pharmaceutical Journal ›› 2016, Vol. 51 ›› Issue (3) : 242-247.

PDF(958 KB)
PDF(958 KB)
Chinese Pharmaceutical Journal ›› 2016, Vol. 51 ›› Issue (3) : 242-247. DOI: 10.11669/cpj.2016.03.021

Cost-Effectiveness Analysis of Insulin Aspart 30 Versus Insulin Glargine in Patients with Type 2 Diabetes in China

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2016, 51(3): 242-247 https://doi.org/10.11669/cpj.2016.03.021

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(958 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉